Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacogenetics of warfarin].

P Kessler1

  • 1Oddĕlení hematologie a transfuziologie Nemocnice Pelhrimov. pkessler@hospital-pe.cz

Vnitrni Lekarstvi
|April 28, 2006
PubMed
Summary

Genetic factors significantly influence warfarin dosage. Key genes like CYP2C9 and VKORC1 explain over half of warfarin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver abscess in «anchovy paste»; Amebiasis alert.

Revista clinica espanola·2021
Same author

[Peripheral truncal blocks-Overview and assessment].

Der Anaesthesist·2020
Same author

Liver abscess in «anchovy paste»; amebiasis alert.

Revista clinica espanola·2020
Same author

The effect of needle tip tracking on procedural time of ultrasound-guided lumbar plexus block: a randomised controlled trial.

Anaesthesia·2019
Same author

Uncertainties and characteristic limits of counting and spectrometric dosimetry systems.

Journal of environmental radioactivity·2019
Same author

Epidural needle insertion : A large registry analysis.

Der Anaesthesist·2018

Area of Science:

  • Pharmacogenetics
  • Clinical Pharmacology
  • Genetics

Background:

  • Warfarin dosage varies significantly among patients.
  • External factors like drug and food interactions influence warfarin efficacy.
  • Genetic predispositions are crucial for optimal warfarin therapy.

Purpose of the Study:

  • To investigate the role of genetic variations in warfarin dosage.
  • To identify specific genes affecting warfarin metabolism and response.
  • To understand the contribution of genetic factors to warfarin's therapeutic effect variability.

Main Methods:

  • Analysis of cytochrome P450 2C9 (CYP2C9) gene polymorphisms.
  • Investigation of Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphisms.
  • Evaluation of genetic variants in gamma-carboxylase, prothrombin, and coagulation factors VII and IX.

Main Results:

  • CYP2C9 polymorphisms affect S-warfarin breakdown rate.
  • VKORC1 polymorphisms influence epoxide reductase activity, a key warfarin target.
  • These two genes account for at least 50% of warfarin effect variability.
  • Other genetic variants also contribute to warfarin's pharmacodynamics.

Conclusions:

  • Genetic factors, particularly CYP2C9 and VKORC1, are major determinants of warfarin response.
  • Pharmacogenetic insights are essential for personalized warfarin dosing.
  • Future research will further elucidate the clinical impact of these genetic findings.

Related Experiment Videos